✦ LIBER ✦

Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands

✍ Scribed by Vencken, P. M. L. H.; Reitsma, W.; Kriege, M.; Mourits, M. J. E.; de Bock, G. H.; de Hullu, J. A.; van Altena, A. M.; Gaarenstroom, K. N.; Vasen, H. F. A.; Adank, M. A.; Schmidt, M. K.; van Beurden, M.; Zweemer, R. P.; Rijcken, F.; Slangen, B. F. M.; Burger, C. W.; Seynaeve, C.

Book ID: 125524128
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 143 KB
Volume: 24
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdt068

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

8006 Improved outcome after first line c

8006 Improved outcome after first line chemotherapy in BRCA1- and BRCA2-associated ovarian cancer compared with sporadic ovarian cancer patients

✍ Seynaeve, C.; Hoogwerf, D.; Kriege, M.; Beugelink, S.; Jager, A.; Collee, J.; Be 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A population-based study of BRCA1 and BR

A population-based study of BRCA1 and BRCA2 mutations in jewish women with epithelial ovarian cancer

✍ Karen H Lu; Daniel W Cramer; Michael G Muto; Evelyn Y Li; Jonathan Niloff; Samue 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 272 KB

Recurrent BRCA1 and BRCA2 germline mutat

Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: A founder mutation of BRCA1 identified in the Chinese population

✍ Ui-Soon Khoo; Kelvin Y.K. Chan; Annie N.Y. Cheung; W.C. Xue; D.H. Shen; K.Y. Fun 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Previous mutational analysis for BRCA gene mutations in sporadic ovarian cancer occurring in Chinese patients in Hong Kong identified six germline BRCA1 mutations and one germline BRCA2 mutation, six of which were novel (Khoo et al., 2000). Knowledge of BRCA gene mutations in the Chinese population

Association of BRCA1 and BRCA2 Mutations

Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer

✍ Yang, Da; Khan, Sofia; Sun, Yan; Hess, Kenneth; Shmulevich, Ilya; Sood, Anil K.; 📂 Article 📅 2011 🏛 American Medical Association 🌐 English ⚖ 486 KB

A High Proportion of DNA Variants of BRC

A High Proportion of DNA Variants of BRCA1 and BRCA2 Is Associated with Aberrant Splicing in Breast/Ovarian Cancer Patients

✍ Sanz, D. J.; Acedo, A.; Infante, M.; Duran, M.; Perez-Cabornero, L.; Esteban-Car 📂 Article 📅 2010 🏛 American Association for Cancer Research 🌐 English ⚖ 411 KB

Phase I/Ib Study of Olaparib and Carbopl

Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses

✍ Lee, J.-M.; Hays, J. L.; Annunziata, C. M.; Noonan, A. M.; Minasian, L.; Zujewsk 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 920 KB